nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—Pentoxifylline—systemic scleroderma	0.13	0.193	CbGbCtD
Toremifene—CYP1A2—Leflunomide—systemic scleroderma	0.124	0.184	CbGbCtD
Toremifene—ABCB1—Lisinopril—systemic scleroderma	0.114	0.169	CbGbCtD
Toremifene—ABCB1—Captopril—systemic scleroderma	0.0853	0.127	CbGbCtD
Toremifene—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0671	0.0996	CbGbCtD
Toremifene—ABCB1—Prednisone—systemic scleroderma	0.0537	0.0796	CbGbCtD
Toremifene—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0402	0.0597	CbGbCtD
Toremifene—CYP3A4—Prednisone—systemic scleroderma	0.0322	0.0477	CbGbCtD
Toremifene—ABCB1—Methotrexate—systemic scleroderma	0.0269	0.04	CbGbCtD
Toremifene—Fatigue—Mometasone—systemic scleroderma	0.000757	0.00232	CcSEcCtD
Toremifene—Thrombocytopenia—Captopril—systemic scleroderma	0.000755	0.00232	CcSEcCtD
Toremifene—Alopecia—Mycophenolic acid—systemic scleroderma	0.000754	0.00231	CcSEcCtD
Toremifene—Back pain—Leflunomide—systemic scleroderma	0.000754	0.00231	CcSEcCtD
Toremifene—Pain—Mometasone—systemic scleroderma	0.000751	0.0023	CcSEcCtD
Toremifene—Mental disorder—Mycophenolic acid—systemic scleroderma	0.000748	0.00229	CcSEcCtD
Toremifene—Malnutrition—Mycophenolic acid—systemic scleroderma	0.000743	0.00228	CcSEcCtD
Toremifene—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00227	CcSEcCtD
Toremifene—Leukopenia—Azathioprine—systemic scleroderma	0.000738	0.00226	CcSEcCtD
Toremifene—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000736	0.00226	CcSEcCtD
Toremifene—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000736	0.00226	CcSEcCtD
Toremifene—Anorexia—Captopril—systemic scleroderma	0.000735	0.00225	CcSEcCtD
Toremifene—Vision blurred—Leflunomide—systemic scleroderma	0.000734	0.00225	CcSEcCtD
Toremifene—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000732	0.00224	CcSEcCtD
Toremifene—Asthenia—Pentoxifylline—systemic scleroderma	0.00073	0.00224	CcSEcCtD
Toremifene—Pruritus—Pentoxifylline—systemic scleroderma	0.00072	0.00221	CcSEcCtD
Toremifene—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00072	0.00221	CcSEcCtD
Toremifene—Back pain—Mycophenolic acid—systemic scleroderma	0.000719	0.0022	CcSEcCtD
Toremifene—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00218	CcSEcCtD
Toremifene—Vision blurred—Mycophenolic acid—systemic scleroderma	0.0007	0.00215	CcSEcCtD
Toremifene—Vertigo—Leflunomide—systemic scleroderma	0.0007	0.00215	CcSEcCtD
Toremifene—Insomnia—Captopril—systemic scleroderma	0.000698	0.00214	CcSEcCtD
Toremifene—Angiopathy—Lisinopril—systemic scleroderma	0.000698	0.00214	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000698	0.00214	CcSEcCtD
Toremifene—Leukopenia—Leflunomide—systemic scleroderma	0.000697	0.00214	CcSEcCtD
Toremifene—Tremor—Mycophenolic acid—systemic scleroderma	0.000696	0.00213	CcSEcCtD
Toremifene—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000693	0.00212	CcSEcCtD
Toremifene—Chills—Lisinopril—systemic scleroderma	0.00069	0.00212	CcSEcCtD
Toremifene—Dyspnoea—Captopril—systemic scleroderma	0.000688	0.00211	CcSEcCtD
Toremifene—Arrhythmia—Lisinopril—systemic scleroderma	0.000687	0.00211	CcSEcCtD
Toremifene—Alopecia—Lisinopril—systemic scleroderma	0.00068	0.00208	CcSEcCtD
Toremifene—Cardiac failure—Prednisone—systemic scleroderma	0.000677	0.00207	CcSEcCtD
Toremifene—Mental disorder—Lisinopril—systemic scleroderma	0.000674	0.00207	CcSEcCtD
Toremifene—Lethargy—Prednisone—systemic scleroderma	0.000674	0.00207	CcSEcCtD
Toremifene—Dizziness—Pentoxifylline—systemic scleroderma	0.000673	0.00206	CcSEcCtD
Toremifene—Decreased appetite—Captopril—systemic scleroderma	0.000671	0.00206	CcSEcCtD
Toremifene—Malnutrition—Lisinopril—systemic scleroderma	0.000669	0.00205	CcSEcCtD
Toremifene—Vertigo—Mycophenolic acid—systemic scleroderma	0.000668	0.00205	CcSEcCtD
Toremifene—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000665	0.00204	CcSEcCtD
Toremifene—Fatigue—Captopril—systemic scleroderma	0.000665	0.00204	CcSEcCtD
Toremifene—Chest pain—Leflunomide—systemic scleroderma	0.000663	0.00203	CcSEcCtD
Toremifene—Constipation—Captopril—systemic scleroderma	0.00066	0.00202	CcSEcCtD
Toremifene—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000659	0.00202	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000659	0.00202	CcSEcCtD
Toremifene—Skin disorder—Azathioprine—systemic scleroderma	0.000654	0.00201	CcSEcCtD
Toremifene—Affect lability—Prednisone—systemic scleroderma	0.00065	0.00199	CcSEcCtD
Toremifene—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000649	0.00199	CcSEcCtD
Toremifene—Back pain—Lisinopril—systemic scleroderma	0.000648	0.00199	CcSEcCtD
Toremifene—Vomiting—Pentoxifylline—systemic scleroderma	0.000647	0.00198	CcSEcCtD
Toremifene—Rash—Pentoxifylline—systemic scleroderma	0.000642	0.00197	CcSEcCtD
Toremifene—Dermatitis—Pentoxifylline—systemic scleroderma	0.000641	0.00197	CcSEcCtD
Toremifene—Headache—Pentoxifylline—systemic scleroderma	0.000638	0.00196	CcSEcCtD
Toremifene—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000637	0.00195	CcSEcCtD
Toremifene—Chest pain—Mycophenolic acid—systemic scleroderma	0.000633	0.00194	CcSEcCtD
Toremifene—Vision blurred—Lisinopril—systemic scleroderma	0.000631	0.00193	CcSEcCtD
Toremifene—Asthenia—Mometasone—systemic scleroderma	0.00063	0.00193	CcSEcCtD
Toremifene—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00063	0.00193	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000628	0.00193	CcSEcCtD
Toremifene—Tremor—Lisinopril—systemic scleroderma	0.000627	0.00192	CcSEcCtD
Toremifene—Mood swings—Prednisone—systemic scleroderma	0.000625	0.00192	CcSEcCtD
Toremifene—Nervous system disorder—Leflunomide—systemic scleroderma	0.000624	0.00191	CcSEcCtD
Toremifene—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000623	0.00191	CcSEcCtD
Toremifene—Pruritus—Mometasone—systemic scleroderma	0.000621	0.00191	CcSEcCtD
Toremifene—Skin disorder—Leflunomide—systemic scleroderma	0.000618	0.00189	CcSEcCtD
Toremifene—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000615	0.00188	CcSEcCtD
Toremifene—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00187	CcSEcCtD
Toremifene—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00186	CcSEcCtD
Toremifene—Oedema—Mycophenolic acid—systemic scleroderma	0.000607	0.00186	CcSEcCtD
Toremifene—Anorexia—Leflunomide—systemic scleroderma	0.000606	0.00186	CcSEcCtD
Toremifene—Nausea—Pentoxifylline—systemic scleroderma	0.000605	0.00185	CcSEcCtD
Toremifene—Chills—Mycophenolate mofetil—systemic scleroderma	0.000605	0.00185	CcSEcCtD
Toremifene—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000602	0.00185	CcSEcCtD
Toremifene—Vertigo—Lisinopril—systemic scleroderma	0.000601	0.00184	CcSEcCtD
Toremifene—Leukopenia—Lisinopril—systemic scleroderma	0.000599	0.00184	CcSEcCtD
Toremifene—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00183	CcSEcCtD
Toremifene—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000595	0.00182	CcSEcCtD
Toremifene—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000594	0.00182	CcSEcCtD
Toremifene—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00181	CcSEcCtD
Toremifene—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000589	0.00181	CcSEcCtD
Toremifene—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000587	0.0018	CcSEcCtD
Toremifene—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000586	0.0018	CcSEcCtD
Toremifene—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000581	0.00178	CcSEcCtD
Toremifene—Anorexia—Mycophenolic acid—systemic scleroderma	0.000578	0.00177	CcSEcCtD
Toremifene—Insomnia—Leflunomide—systemic scleroderma	0.000575	0.00176	CcSEcCtD
Toremifene—Chest pain—Lisinopril—systemic scleroderma	0.00057	0.00175	CcSEcCtD
Toremifene—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00174	CcSEcCtD
Toremifene—Dyspnoea—Leflunomide—systemic scleroderma	0.000567	0.00174	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000566	0.00174	CcSEcCtD
Toremifene—Lethargy—Methotrexate—systemic scleroderma	0.000563	0.00173	CcSEcCtD
Toremifene—Vomiting—Mometasone—systemic scleroderma	0.000559	0.00171	CcSEcCtD
Toremifene—Rash—Mometasone—systemic scleroderma	0.000554	0.0017	CcSEcCtD
Toremifene—Asthenia—Captopril—systemic scleroderma	0.000554	0.0017	CcSEcCtD
Toremifene—Dermatitis—Mometasone—systemic scleroderma	0.000553	0.0017	CcSEcCtD
Toremifene—Decreased appetite—Leflunomide—systemic scleroderma	0.000553	0.00169	CcSEcCtD
Toremifene—Headache—Mometasone—systemic scleroderma	0.00055	0.00169	CcSEcCtD
Toremifene—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00168	CcSEcCtD
Toremifene—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000549	0.00168	CcSEcCtD
Toremifene—Insomnia—Mycophenolic acid—systemic scleroderma	0.000549	0.00168	CcSEcCtD
Toremifene—Fatigue—Leflunomide—systemic scleroderma	0.000548	0.00168	CcSEcCtD
Toremifene—Oedema—Lisinopril—systemic scleroderma	0.000546	0.00168	CcSEcCtD
Toremifene—Pruritus—Captopril—systemic scleroderma	0.000546	0.00167	CcSEcCtD
Toremifene—Constipation—Leflunomide—systemic scleroderma	0.000544	0.00167	CcSEcCtD
Toremifene—Pain—Leflunomide—systemic scleroderma	0.000544	0.00167	CcSEcCtD
Toremifene—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000541	0.00166	CcSEcCtD
Toremifene—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000535	0.00164	CcSEcCtD
Toremifene—Skin disorder—Lisinopril—systemic scleroderma	0.000531	0.00163	CcSEcCtD
Toremifene—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000528	0.00162	CcSEcCtD
Toremifene—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000527	0.00162	CcSEcCtD
Toremifene—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000527	0.00162	CcSEcCtD
Toremifene—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000525	0.00161	CcSEcCtD
Toremifene—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000524	0.00161	CcSEcCtD
Toremifene—Fatigue—Mycophenolic acid—systemic scleroderma	0.000523	0.0016	CcSEcCtD
Toremifene—Mood swings—Methotrexate—systemic scleroderma	0.000523	0.0016	CcSEcCtD
Toremifene—Nausea—Mometasone—systemic scleroderma	0.000522	0.0016	CcSEcCtD
Toremifene—Anorexia—Lisinopril—systemic scleroderma	0.000521	0.0016	CcSEcCtD
Toremifene—Weight increased—Prednisone—systemic scleroderma	0.000519	0.00159	CcSEcCtD
Toremifene—Ataxia—Methotrexate—systemic scleroderma	0.000519	0.00159	CcSEcCtD
Toremifene—Pain—Mycophenolic acid—systemic scleroderma	0.000519	0.00159	CcSEcCtD
Toremifene—Constipation—Mycophenolic acid—systemic scleroderma	0.000519	0.00159	CcSEcCtD
Toremifene—Dizziness—Captopril—systemic scleroderma	0.00051	0.00156	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000509	0.00156	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000502	0.00154	CcSEcCtD
Toremifene—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000499	0.00153	CcSEcCtD
Toremifene—Myocardial infarction—Prednisone—systemic scleroderma	0.000499	0.00153	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000499	0.00153	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—systemic scleroderma	0.000499	0.00153	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000496	0.00152	CcSEcCtD
Toremifene—Insomnia—Lisinopril—systemic scleroderma	0.000494	0.00152	CcSEcCtD
Toremifene—Vomiting—Captopril—systemic scleroderma	0.000491	0.0015	CcSEcCtD
Toremifene—Dyspnoea—Lisinopril—systemic scleroderma	0.000487	0.00149	CcSEcCtD
Toremifene—Rash—Captopril—systemic scleroderma	0.000486	0.00149	CcSEcCtD
Toremifene—Dermatitis—Captopril—systemic scleroderma	0.000486	0.00149	CcSEcCtD
Toremifene—Headache—Captopril—systemic scleroderma	0.000483	0.00148	CcSEcCtD
Toremifene—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000479	0.00147	CcSEcCtD
Toremifene—Decreased appetite—Lisinopril—systemic scleroderma	0.000475	0.00146	CcSEcCtD
Toremifene—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000472	0.00145	CcSEcCtD
Toremifene—Fatigue—Lisinopril—systemic scleroderma	0.000471	0.00144	CcSEcCtD
Toremifene—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000469	0.00144	CcSEcCtD
Toremifene—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000469	0.00144	CcSEcCtD
Toremifene—Constipation—Lisinopril—systemic scleroderma	0.000467	0.00143	CcSEcCtD
Toremifene—Pain—Lisinopril—systemic scleroderma	0.000467	0.00143	CcSEcCtD
Toremifene—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00143	CcSEcCtD
Toremifene—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000463	0.00142	CcSEcCtD
Toremifene—Nausea—Captopril—systemic scleroderma	0.000458	0.0014	CcSEcCtD
Toremifene—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000456	0.0014	CcSEcCtD
Toremifene—Asthenia—Leflunomide—systemic scleroderma	0.000456	0.0014	CcSEcCtD
Toremifene—Pruritus—Leflunomide—systemic scleroderma	0.00045	0.00138	CcSEcCtD
Toremifene—Dizziness—Azathioprine—systemic scleroderma	0.000445	0.00137	CcSEcCtD
Toremifene—Asthenia—Mycophenolic acid—systemic scleroderma	0.000435	0.00133	CcSEcCtD
Toremifene—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00133	CcSEcCtD
Toremifene—Pruritus—Mycophenolic acid—systemic scleroderma	0.000429	0.00132	CcSEcCtD
Toremifene—Vomiting—Azathioprine—systemic scleroderma	0.000428	0.00131	CcSEcCtD
Toremifene—Eye disorder—Prednisone—systemic scleroderma	0.000427	0.00131	CcSEcCtD
Toremifene—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00131	CcSEcCtD
Toremifene—Rash—Azathioprine—systemic scleroderma	0.000425	0.0013	CcSEcCtD
Toremifene—Dermatitis—Azathioprine—systemic scleroderma	0.000424	0.0013	CcSEcCtD
Toremifene—Headache—Azathioprine—systemic scleroderma	0.000422	0.00129	CcSEcCtD
Toremifene—Dizziness—Leflunomide—systemic scleroderma	0.00042	0.00129	CcSEcCtD
Toremifene—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00128	CcSEcCtD
Toremifene—Angiopathy—Prednisone—systemic scleroderma	0.000414	0.00127	CcSEcCtD
Toremifene—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000413	0.00127	CcSEcCtD
Toremifene—Pain—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00126	CcSEcCtD
Toremifene—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00126	CcSEcCtD
Toremifene—Arrhythmia—Prednisone—systemic scleroderma	0.000408	0.00125	CcSEcCtD
Toremifene—Sweating—Methotrexate—systemic scleroderma	0.000408	0.00125	CcSEcCtD
Toremifene—Vomiting—Leflunomide—systemic scleroderma	0.000404	0.00124	CcSEcCtD
Toremifene—Alopecia—Prednisone—systemic scleroderma	0.000404	0.00124	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000402	0.00123	CcSEcCtD
Toremifene—Dizziness—Mycophenolic acid—systemic scleroderma	0.000401	0.00123	CcSEcCtD
Toremifene—Rash—Leflunomide—systemic scleroderma	0.000401	0.00123	CcSEcCtD
Toremifene—Dermatitis—Leflunomide—systemic scleroderma	0.000401	0.00123	CcSEcCtD
Toremifene—Mental disorder—Prednisone—systemic scleroderma	0.0004	0.00123	CcSEcCtD
Toremifene—Nausea—Azathioprine—systemic scleroderma	0.0004	0.00123	CcSEcCtD
Toremifene—Headache—Leflunomide—systemic scleroderma	0.000398	0.00122	CcSEcCtD
Toremifene—Malnutrition—Prednisone—systemic scleroderma	0.000398	0.00122	CcSEcCtD
Toremifene—Asthenia—Lisinopril—systemic scleroderma	0.000392	0.0012	CcSEcCtD
Toremifene—Pruritus—Lisinopril—systemic scleroderma	0.000387	0.00119	CcSEcCtD
Toremifene—Vomiting—Mycophenolic acid—systemic scleroderma	0.000386	0.00118	CcSEcCtD
Toremifene—Rash—Mycophenolic acid—systemic scleroderma	0.000382	0.00117	CcSEcCtD
Toremifene—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000382	0.00117	CcSEcCtD
Toremifene—Headache—Mycophenolic acid—systemic scleroderma	0.00038	0.00117	CcSEcCtD
Toremifene—Nausea—Leflunomide—systemic scleroderma	0.000378	0.00116	CcSEcCtD
Toremifene—Vision blurred—Prednisone—systemic scleroderma	0.000375	0.00115	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—systemic scleroderma	0.000368	0.00113	CcSEcCtD
Toremifene—Dizziness—Lisinopril—systemic scleroderma	0.000361	0.00111	CcSEcCtD
Toremifene—Nausea—Mycophenolic acid—systemic scleroderma	0.00036	0.0011	CcSEcCtD
Toremifene—Vertigo—Prednisone—systemic scleroderma	0.000357	0.0011	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—systemic scleroderma	0.000357	0.00109	CcSEcCtD
Toremifene—Vomiting—Lisinopril—systemic scleroderma	0.000347	0.00107	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—systemic scleroderma	0.000346	0.00106	CcSEcCtD
Toremifene—Rash—Lisinopril—systemic scleroderma	0.000345	0.00106	CcSEcCtD
Toremifene—Dermatitis—Lisinopril—systemic scleroderma	0.000344	0.00106	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000344	0.00105	CcSEcCtD
Toremifene—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00105	CcSEcCtD
Toremifene—Chills—Methotrexate—systemic scleroderma	0.000343	0.00105	CcSEcCtD
Toremifene—Headache—Lisinopril—systemic scleroderma	0.000342	0.00105	CcSEcCtD
Toremifene—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000339	0.00104	CcSEcCtD
Toremifene—Alopecia—Methotrexate—systemic scleroderma	0.000337	0.00103	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000336	0.00103	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—systemic scleroderma	0.000334	0.00103	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—systemic scleroderma	0.000332	0.00102	CcSEcCtD
Toremifene—Nausea—Lisinopril—systemic scleroderma	0.000325	0.000995	CcSEcCtD
Toremifene—Oedema—Prednisone—systemic scleroderma	0.000325	0.000995	CcSEcCtD
Toremifene—Back pain—Methotrexate—systemic scleroderma	0.000321	0.000985	CcSEcCtD
Toremifene—Nervous system disorder—Prednisone—systemic scleroderma	0.000318	0.000976	CcSEcCtD
Toremifene—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000317	0.000971	CcSEcCtD
Toremifene—Skin disorder—Prednisone—systemic scleroderma	0.000315	0.000966	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisone—systemic scleroderma	0.000314	0.000962	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—systemic scleroderma	0.000313	0.00096	CcSEcCtD
Toremifene—Anorexia—Prednisone—systemic scleroderma	0.000309	0.000948	CcSEcCtD
Toremifene—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000933	CcSEcCtD
Toremifene—Rash—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000925	CcSEcCtD
Toremifene—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000925	CcSEcCtD
Toremifene—Headache—Mycophenolate mofetil—systemic scleroderma	0.0003	0.000919	CcSEcCtD
Toremifene—Vertigo—Methotrexate—systemic scleroderma	0.000299	0.000915	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—systemic scleroderma	0.000297	0.000912	CcSEcCtD
Toremifene—Insomnia—Prednisone—systemic scleroderma	0.000293	0.0009	CcSEcCtD
Toremifene—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000872	CcSEcCtD
Toremifene—Chest pain—Methotrexate—systemic scleroderma	0.000283	0.000867	CcSEcCtD
Toremifene—Decreased appetite—Prednisone—systemic scleroderma	0.000282	0.000865	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000281	0.000861	CcSEcCtD
Toremifene—Fatigue—Prednisone—systemic scleroderma	0.00028	0.000858	CcSEcCtD
Toremifene—Constipation—Prednisone—systemic scleroderma	0.000277	0.000851	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—systemic scleroderma	0.000266	0.000815	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000266	0.000814	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—systemic scleroderma	0.000263	0.000808	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000262	0.000804	CcSEcCtD
Toremifene—Anorexia—Methotrexate—systemic scleroderma	0.000259	0.000793	CcSEcCtD
Toremifene—Insomnia—Methotrexate—systemic scleroderma	0.000245	0.000752	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—systemic scleroderma	0.000242	0.000741	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—systemic scleroderma	0.000236	0.000723	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000234	0.000718	CcSEcCtD
Toremifene—Fatigue—Methotrexate—systemic scleroderma	0.000234	0.000717	CcSEcCtD
Toremifene—Asthenia—Prednisone—systemic scleroderma	0.000233	0.000714	CcSEcCtD
Toremifene—Pain—Methotrexate—systemic scleroderma	0.000232	0.000711	CcSEcCtD
Toremifene—Pruritus—Prednisone—systemic scleroderma	0.00023	0.000704	CcSEcCtD
Toremifene—Dizziness—Prednisone—systemic scleroderma	0.000215	0.000658	CcSEcCtD
Toremifene—Vomiting—Prednisone—systemic scleroderma	0.000206	0.000633	CcSEcCtD
Toremifene—Rash—Prednisone—systemic scleroderma	0.000205	0.000627	CcSEcCtD
Toremifene—Dermatitis—Prednisone—systemic scleroderma	0.000204	0.000627	CcSEcCtD
Toremifene—Headache—Prednisone—systemic scleroderma	0.000203	0.000623	CcSEcCtD
Toremifene—Asthenia—Methotrexate—systemic scleroderma	0.000195	0.000597	CcSEcCtD
Toremifene—Nausea—Prednisone—systemic scleroderma	0.000193	0.000591	CcSEcCtD
Toremifene—Pruritus—Methotrexate—systemic scleroderma	0.000192	0.000588	CcSEcCtD
Toremifene—Dizziness—Methotrexate—systemic scleroderma	0.000179	0.00055	CcSEcCtD
Toremifene—Vomiting—Methotrexate—systemic scleroderma	0.000172	0.000529	CcSEcCtD
Toremifene—Rash—Methotrexate—systemic scleroderma	0.000171	0.000524	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—systemic scleroderma	0.000171	0.000524	CcSEcCtD
Toremifene—Headache—Methotrexate—systemic scleroderma	0.00017	0.000521	CcSEcCtD
Toremifene—Nausea—Methotrexate—systemic scleroderma	0.000161	0.000494	CcSEcCtD
